Menu
Not yet recruiting NCT07500909

Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients

Observational Deafness, Bilateral

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: neurophysiological assessment, Cognitive, behavioral and quality of life assessment.
Who it may be relevant to
Registry conditions: Deafness, Bilateral. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This study posits that central top-down processes (attention, inhibition), marked by alpha oscillations in EEG, play a key role. Understanding the evolution of these neuronal signatures and their link to pre-implantation visual dependence could allow the identification of biomarkers predictive of the success of auditory rehabilitation.

Detailed description

Profound bilateral deafness leads to sensory deprivation and neuronal reorganization ( visual recruitment of the auditory cortex). Although cochlear implants restore hearing, comprehension performance varies considerably. Peripheral factors explain only 40% of this variance. This study posits that central top-down processes (attention, inhibition), marked by alpha oscillations in EEG, play a key role. Understanding the evolution of these neuronal signatures and their link to pre-implantation visual dependence could allow the identification of biomarkers predictive of the success of auditory rehabilitation.

Interventions

  • Other neurophysiological assessment
    Electroencephalography and eye tracking
  • Behavioral Cognitive, behavioral and quality of life assessment
    Cognitive anfd behavioral assessment : Speech recognition test in silence (MBAA) and in noise, verbal working memory task with distractors, Trail Making Test and MoCA test. Quality of lige assessment : This questionnaire is a set of scales concerning patients' hearing abilities, experience, and listening skills in different situations. For each question, the patient must answer by choosing a number between 1 (not at all) and 10 (perfectly).

Primary outcome measures

  • Evolution of oscillatory signatures [Time frame: 6 months]
Secondary outcome measures (5)
  • EEG (alpha) signatures and eye-tracking [Time frame: 6 months]
  • Speech recognition performance [Time frame: 6 months]
  • alpha modulation and memory/auditory [Time frame: 6 months]
  • audiovisual, visual and auditory comparison [Time frame: 6 months]
  • SSQ [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

For cochlear implant patients:

  • Adult patients
  • Profound bilateral hearing loss requiring a first cochlear implant
  • Normal cochlear anatomy (confirmed by preoperative imaging)
  • Full insertion of the cochlear electrode array planned
  • Acceptance of the protocol and signing of the informed consent form
  • Enrollment in a social security or equivalent plan

For young patients with normal hearing:

  • Adult patients aged 18 to 40
  • Normal and symmetrical hearing
  • Acceptance of the protocol and signature of the informed consent form
  • Affiliation with a social security scheme or equivalent

For older patients with normal hearing:

  • Patients over 50 years of age, matched by gender and age (+/- 2 years) with the cochlear implant patient group
  • Normal and symmetrical hearing, with hearing thresholds < 20 dB HL at 2 kHz and < 40 dB HL at 4 kHz
  • Acceptance of the protocol and signature of the informed consent form
  • Affiliation with a social security scheme or equivalent

For experienced cochlear implant recipients:

  • Adult patients.
  • Unilateral cochlear implant activated for 1 year or more.
  • Disyllabic word recognition score at 60 dB in free field of 70% or higher.
  • Acceptance of the protocol and signature of the informed consent form.
  • Affiliation with a social security plan or equivalent.

For severely deaf patients fitted with hearing aids:

  • Adult patients.
  • Severe bilateral hearing loss.
  • Rehabilitation with one or two optimally fitted hearing aids.
  • Acceptance of the protocol and signing of the informed consent form.
  • Enrollment in a social security or equivalent health insurance plan.

Exclusion criteria

  • History of associated neurological pathology
  • Etiologies with unfavorable prognoses, such as recurrent chronic otitis media: These conditions are associated with a poor prognosis due to chronic inflammation that can affect the cochlea
  • Duration of profound bilateral deafness exceeding 5 years (worse prognosis)
  • Contraindications to EEG or other neurophysiological examinations within the study (for all groups)
  • Cognitive impairment confirmed by the MOCA test for the cochlear implant patient group and the group of elderly subjects with normal hearing
  • Use of psychotropic medications that may interfere with the results of cognitive or neurological tests
  • History of epilepsy or other major neurological disorders
  • Pregnancy or breastfeeding
  • Participation in another interventional research protocol or one that impacts the criteria studied in this project
  • Individuals under legal guardianship (guardianship, tutorship, curatorship, institutionalized, or under a future protection mandate)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07500909 · RC31/26/0005 · 2026-A00163-48

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗